Coronary Sinus Reducer Objective Impact on SymptoMs, Ischaemia and miCrovascular Resistance in Non-obstructive Hypertrophic CardioMyopathy
This research study is for people with a heart condition called hypertrophic cardiomyopathy (HCM), where the heart muscle is thicker than usual. Specifically, it's for those whose blood flow out of the heart isn't blocked, but they still have symptoms like chest pain and breathlessness. These symptoms might be due to tiny blood vessels in the heart not supplying enough oxygen. The study is testing a small device called a coronary sinus reducer. This device is placed into a heart vein and is designed to improve blood flow to the heart muscle. Fifty adults will take part, with half receiving the device and half a dummy procedure. The aim is to see if the device reduces symptoms and improves blood flow.
At a glance
What is this study about?
This study focuses on a heart condition called hypertrophic cardiomyopathy (HCM). In HCM, your heart muscle becomes thicker than normal. While it's a serious condition, in some cases, the blood flow out of the heart isn't blocked. However, many people with this type of HCM still suffer from symptoms like chest pain, feeling breathless, and finding daily activities difficult. We think these symptoms might be happening because the tiny blood vessels within the thickened heart muscle aren't delivering enough blood and oxygen, especially when the heart has to work harder, like during exercise or stress.
Currently, there aren't many good treatment options available for people with this specific type of HCM and ongoing symptoms. This study aims to explore a new potential treatment. We are testing a small device called a coronary sinus reducer (CSR). This device is carefully placed into a vein of your heart using a thin tube called a catheter. The idea behind the CSR is that it helps to improve blood flow to areas of the heart muscle that aren't getting enough oxygen.
By carefully studying this device, we hope to find out if it can genuinely improve blood flow to the heart and reduce those troublesome symptoms. The results from this study could be very important, potentially offering a new treatment option for people living with non-obstructive HCM and helping us to understand this condition better.
Key takeaways
- This study is testing a new device for a specific type of thickened heart muscle condition (non-obstructive HCM).
- The device aims to improve blood flow to the heart and reduce symptoms like chest pain and breathlessness.
- Half of the participants will receive the device, and half will have a dummy procedure for comparison.
- Taking part involves a procedure, regular symptom tracking via an app, and follow-up assessments over six months.
- This research hopes to find a new treatment option and better understand this heart condition.
Who may be eligible?
This study is looking for adults aged 18 or over who have a specific type of hypertrophic cardiomyopathy (HCM). You would be considered if your heart muscle is thickened but the blood flow out of your heart is not significantly blocked. You also need to be experiencing ongoing symptoms, even with your current medication, and a special heart MRI scan should show that parts of your heart muscle aren't getting enough blood flow when under stress.
There are certain reasons why you might not be able to join. For instance, if you have very weak heart muscle, severe kidney problems, or if your heart has very high pressure in one of its chambers. Also, if you have another significant heart condition that blocks your arteries, or if you can't have certain types of MRI scans or contrast dyes, you wouldn't be able to take part. Women who are pregnant also cannot participate.
If you've been on certain new medications for HCM in the last six months, or if you can't take blood-thinning medicines, this study might not be right for you. The researchers will check all these details carefully to make sure the study is safe and suitable for everyone involved.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Have you been diagnosed with hypertrophic cardiomyopathy (HCM) where blood flow out of your heart is NOT significantly blocked?
- Do you still have symptoms (like chest pain or breathlessness) despite your current treatments?
- Have you had a heart MRI scan that shows parts of your heart muscle aren't getting enough blood supply?
- Do you NOT have severe kidney problems or significantly weak heart muscle?
- Are you able to have MRI scans and related contrast dyes?
What does participation involve?
If you decide to take part, the study will involve several steps over about six months. Firstly, you'll have an initial assessment including symptom questionnaires and you'll be set up with a smartphone app to record your daily symptoms. You'll use this app for two weeks to make sure your symptoms are consistent. If you don't have any symptoms during this time, you won't continue in the study.
Next, you'll have a procedure in a hospital lab. You'll be given medicine to make you feel very relaxed (sedated), and headphones to help you stay calm and unaware of what's happening. You will then be randomly chosen to receive either the coronary sinus reducer device or a dummy procedure. You won't know which one you've had. During this procedure, the doctors will take some measurements from a vein in your neck and also take blood samples from your heart.
Some participants will also have an extra, more detailed heart examination where doctors look at your heart's blood vessels using thin wires and special measurements. This extra check happens before you have the device or dummy procedure. After the procedure, you will continue to use the smartphone app to report your symptoms daily for six months. At the end of the six months, you'll return for repeat questionnaires and another special heart MRI scan. If you had the extra heart examination at the start, you'll be invited to have it again at six months to see if there have been any changes.
Potential risks and benefits
Locations (8)
- University Hospitals Bristol and Weston Nhs Foundation TrustVerified postcodeBristol, United Kingdom
- Liverpool Heart and Chest Hospital Nhs Foundation TrustVerified postcodeLiverpool, United Kingdom
- Barts Health Nhs TrustVerified postcodeLondon, United Kingdom
- Guy'S and St Thomas' Nhs Foundation TrustVerified postcodeLondon, United Kingdom
- Imperial College Healthcare NHS TrustVerified postcodeLondon, United Kingdom
- Oxford University Hospitals Nhs Foundation TrustVerified postcodeOxford, United Kingdom
- University Hospitals Dorset Nhs Foundation TrustVerified postcodePoole, United Kingdom
- Mid and South Essex Nhs Foundation TrustVerified postcodeWestcliff-on-Sea, United Kingdom
Common questions
What is 'non-obstructive hypertrophic cardiomyopathy'?
It's a heart condition where your heart muscle is thick, but the blood flowing out of your heart isn't blocked. Many people still get symptoms like chest pain and breathlessness.
What is a 'coronary sinus reducer'?
It's a small device placed inside a vein in your heart. It's designed to help improve blood flow and oxygen supply to the heart muscle, potentially reducing symptoms.
Why is there a 'placebo procedure'?
A placebo (or dummy) procedure helps researchers fairly compare the new device. It ensures any improvements seen are definitely due to the device and not just the natural course of the condition or the 'effect' of having a procedure.
Will I know if I get the device or the dummy procedure?
No, neither you nor the study team will know which procedure you received until after the main assessments are completed at six months. This is called 'blinding' and helps keep the study fair.
What is the ORBITA-app?
It's a smartphone app you'll use to record your symptoms daily. This helps the study team understand how your symptoms change over time.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.